Of note, whole genome sequencing of the miR-142−/−BCR-ABL LSKs failed to show any additional genomic “hits” when compared with that of miR-142+/+BCR-ABL LSKs, suggesting that miR-142 deficit alone sufficed in stably transforming CP-LSCs into BC-LSCs. The gene discussed is ABL1; the disease is breast cancer.